Tenon Medical, Inc. 8-K

What Happened

• Tenon Medical, Inc. (TNON) filed an 8-K on Feb. 6, 2026 to announce a press release dated Feb. 5, 2026 reporting unaudited preliminary revenue for the fourth quarter and full year 2025. The company reported Q4 2025 revenue of $1.45–$1.48 million (about a 90% increase versus Q4 2024) and full-year 2025 revenue of $3.91–$3.94 million (about a 20% increase versus 2024). Tenon said it will release audited financial results for the quarter and year ended Dec. 31, 2025 after market close on March 19, 2026 and will hold a conference call the same day at 4:30 p.m. ET.

Key Details

• Press release date: Feb. 5, 2026; 8-K filed Feb. 6, 2026.
• Q4 2025 unaudited revenue: $1.45–$1.48 million (~90% YoY increase).
• FY2025 unaudited revenue: $3.91–$3.94 million (~20% YoY increase).
• Full results and management call scheduled after market close on March 19, 2026 at 4:30 p.m. ET.

Why It Matters

• These preliminary, unaudited revenue figures signal meaningful top-line growth year-over-year, particularly in the quarter, which investors often view as a sign of accelerating sales momentum.
• The company will provide final audited results and commentary on March 19, 2026; that report and the conference call may give more detail on margins, profitability and the drivers behind the revenue gains.
• Retail investors should note the preliminary nature of the figures (unaudited) and watch the March 19 release for confirmed results and any forward-looking guidance.